The Benefit-Risk Assessment of Medicines: Experience of a Consortium of Medium-Sized Regulatory Authorities
Crossref DOI link: https://doi.org/10.1177/2168479017696260
Published Online: 2017-12-30
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McAuslane, Neil
Leong, James
Liberti, Lawrence
Walker, Stuart
Text and Data Mining valid from 2017-09-01
Article History
Received: 12 September 2016
Accepted: 17 January 2017
First Online: 30 December 2017